Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsLEXEO Therapeutics announced that the European Commission has granted Orphan Drug Designation to LX1004 for the treatment of CLN2 Batten disease.
[LEXEO Therapeutics]
Home Newsletters Neural Cell News LEXEO Therapeutics Receives Orphan Drug Designation for LX1004 from European Commission
